Inflamalps Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Inflamalps General Information
Description
Operator of a biopharmaceutical company intended to progress in the treatment of chronic inflammatory diseases. The company engages in discovering and developing novel molecules with a focus on ophthalmological and dermatological diseases, helping find reliable cures for such chronic diseases by leveraging technological development and professional research.
Contact Information
Website
www.inflamalps.comCorporate Office
- Route De L'Ile-Au-Bois 1A
- 1870 Monthey
- Switzerland
Corporate Office
- Route De L'Ile-Au-Bois 1A
- 1870 Monthey
- Switzerland
Inflamalps Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Inflamalps Patents
Inflamalps Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026209841-A1 | Compounds such as n-hydroxyapiosporamide or didymellamides for use in the treatment of fungal infection such as candida | Pending | 01-Apr-2025 | ||
| EP-4493204-A1 | Aqueous extract from the aerial parts of a plant of the genus aster and uses thereof | Pending | 16-Mar-2022 | ||
| WO-2023174981-A1 | Aqueous extract from the aerial parts of a plant of the genus aster and uses thereof | Inactive | 16-Mar-2022 | ||
| FR-3133536-A1 | Aqueous extract of the aerial parts of a plant of the aster genus and its uses | Active | 16-Mar-2022 | ||
| FR-3133536-B1 | Aqueous extract of the aerial parts of a plant of the genus aster and its uses | Active | 16-Mar-2022 | A61K36/28 |
Inflamalps Signals
Inflamalps Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Inflamalps FAQs
-
When was Inflamalps founded?
Inflamalps was founded in 2012.
-
Where is Inflamalps headquartered?
Inflamalps is headquartered in Monthey, Switzerland.
-
What is the size of Inflamalps?
Inflamalps has 10 total employees.
-
What industry is Inflamalps in?
Inflamalps’s primary industry is Drug Discovery.
-
Is Inflamalps a private or public company?
Inflamalps is a Private company.
-
What is Inflamalps’s current revenue?
The current revenue for Inflamalps is .
-
How much funding has Inflamalps raised over time?
Inflamalps has raised $1.89M.
-
Who are Inflamalps’s investors?
Fondation The Ark and Waarde Capital have invested in Inflamalps.
-
When was Inflamalps acquired?
Inflamalps was acquired on 01-Sep-2022.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process